Nedimesken (Talk | contribs) |
|||
(10 intermediate revisions by 2 users not shown) | |||
Line 33: | Line 33: | ||
<td>FucO / L-1,2-propanediol oxidoreductase</td> | <td>FucO / L-1,2-propanediol oxidoreductase</td> | ||
<td>Tugba Inanc & Ceyhun Kayihan</td> | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
− | <td> | + | <td>1350 bp</td> |
</tr> | </tr> | ||
<tr class="warning" style="font-size: 17px; color: #000000"> | <tr class="warning" style="font-size: 17px; color: #000000"> | ||
Line 40: | Line 40: | ||
<td>GSH/ Bifunctional gamma-glutamate-cysteine ligase/Glutathione synthetase</td> | <td>GSH/ Bifunctional gamma-glutamate-cysteine ligase/Glutathione synthetase</td> | ||
<td>Tugba Inanc & Ceyhun Kayihan</td> | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
− | <td> | + | <td>2466 bp</td> |
</tr> | </tr> | ||
<tr class="info"> | <tr class="info"> | ||
Line 47: | Line 47: | ||
<td>Dual Expression of FucO and GSH</td> | <td>Dual Expression of FucO and GSH</td> | ||
<td>Tugba Inanc & Ceyhun Kayihan</td> | <td>Tugba Inanc & Ceyhun Kayihan</td> | ||
− | <td> | + | <td>3644 bp</td> |
</tr> | </tr> | ||
</tbody> | </tbody> | ||
Line 77: | Line 77: | ||
<img src="https://static.igem.org/mediawiki/2018/0/03/T--METU_HS_Ankara--cparts02.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/0/03/T--METU_HS_Ankara--cparts02.jpg" /> | ||
<br /> | <br /> | ||
− | <i | + | <i class="parts-info"> |
Figure 1: Circuit design of Composite part 1 with FucO gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">BBa_K2571003.</a> | Figure 1: Circuit design of Composite part 1 with FucO gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571003">BBa_K2571003.</a> | ||
− | Our construct includes a strong promoter, RBS, | + | Our construct includes a strong promoter, RBS, FucO and double terminator. |
</i> | </i> | ||
Line 93: | Line 93: | ||
<img src="https://static.igem.org/mediawiki/2018/0/0c/T--METU_HS_Ankara--cparts0121566415.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/0/0c/T--METU_HS_Ankara--cparts0121566415.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
− | Figure 2: Effect of FucO overexpression in LY180 (Wang <i>et al.</i>, 2011). The | + | Figure 2: Effect of FucO overexpression in LY180 (Wang <i>et al.</i>, 2011). The cell mass was observed in furfural containing medium. The FucO gene expressing |
− | L-1,2-propanediol oxidoreductase reduces the effect of furfural. The specific death rate of normal bacteria is observed to be | + | L-1,2-propanediol oxidoreductase reduces the effect of furfural. The specific death rate of normal bacteria is observed to be higher than the specific |
death rate of bacteria with FucO gene. Thus, FucO is shown to increase the tolerance and lifespan of bacteria. | death rate of bacteria with FucO gene. Thus, FucO is shown to increase the tolerance and lifespan of bacteria. | ||
</i> | </i> | ||
Line 106: | Line 106: | ||
<img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts04.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts04.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
Figure 3: The overexpression of FucO and YqhD and relationships with furfural resistance traits, metabolism, and reducing cofactors (Wang <i>et al.</i>, 2013). | Figure 3: The overexpression of FucO and YqhD and relationships with furfural resistance traits, metabolism, and reducing cofactors (Wang <i>et al.</i>, 2013). | ||
</i> | </i> | ||
<p> | <p> | ||
− | Because the native conversion of NADH to NADPH in E. coli is insufficient to revitalize the NADPH pool during fermentation, the actions shouldn’t be | + | Because the native conversion of NADH to NADPH in <i>E. coli</i> is insufficient to revitalize the NADPH pool during fermentation, the actions shouldn’t be |
interfering with NADPH metabolism (Wang <i>et al.</i>, 2011). Thus, the overexpression of plasmid-based NADH-dependent propanediol oxidoreductase (FucO) gene | interfering with NADPH metabolism (Wang <i>et al.</i>, 2011). Thus, the overexpression of plasmid-based NADH-dependent propanediol oxidoreductase (FucO) gene | ||
reduces furfural to ultimately improve furfural resistance without detrimentally affecting the biosynthesis of NADPH (Wang <i>et al.</i>, 2011). | reduces furfural to ultimately improve furfural resistance without detrimentally affecting the biosynthesis of NADPH (Wang <i>et al.</i>, 2011). | ||
Line 118: | Line 118: | ||
<img width="500" src="https://static.igem.org/mediawiki/2018/b/be/T--METU_HS_Ankara--cparts05.gif" /> | <img width="500" src="https://static.igem.org/mediawiki/2018/b/be/T--METU_HS_Ankara--cparts05.gif" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info" style="margin-bottom: 20px"> |
− | Figure 4: 3D protein structure of L-1,2-propanediol oxidoreductase | + | Figure 4: 3D protein structure of L-1,2-propanediol oxidoreductase. |
</i> | </i> | ||
Line 129: | Line 129: | ||
<img width="500" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | <img width="500" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info" style="line-height: 0px !important"> |
Figure 5: BBa_K2571003 check with FucO left and VR primers. Expected band length: 754 bp. Last three wells show positive results. | Figure 5: BBa_K2571003 check with FucO left and VR primers. Expected band length: 754 bp. Last three wells show positive results. | ||
</i> | </i> | ||
Line 156: | Line 156: | ||
<h3>Composite 2:</h3> | <h3>Composite 2:</h3> | ||
− | <h4>GSH:Bifunctional gamma-glutamate-cysteine ligase/ | + | <h4>GSH:Bifunctional gamma-glutamate-cysteine ligase/Glutathione synthetase</h4> |
<p> | <p> | ||
Line 173: | Line 173: | ||
<img width="500" src="https://static.igem.org/mediawiki/2018/c/cd/T--METU_HS_Ankara--cparts08.gif" /> | <img width="500" src="https://static.igem.org/mediawiki/2018/c/cd/T--METU_HS_Ankara--cparts08.gif" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
− | Figure 6: 3D protein structure of Bifunctional gamma-glutamate-cysteine ligase | + | Figure 6: 3D protein structure of Bifunctional gamma-glutamate-cysteine ligase. |
</i> | </i> | ||
Line 184: | Line 184: | ||
<p> | <p> | ||
− | Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), GSH as protein coding region, double terminator (B0015) and suffix. This part enables our E. | + | Our circuit consists of prefix, a strong promoter (J23100), RBS (B0034), GSH as protein coding region, double terminator (B0015) and suffix. This part enables our <i>E. coli</i> KO11 strain to overexpress oxidised Glutathione to reduce oxidative stress, increasing its lifespan (Lu, 2013). Our construct was inserted into pSB1C3 and |
− | + | ||
delivered to the Registry. | delivered to the Registry. | ||
</p> | </p> | ||
Line 191: | Line 190: | ||
<img src="https://static.igem.org/mediawiki/2018/b/b4/T--METU_HS_Ankara--cparts09.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/b/b4/T--METU_HS_Ankara--cparts09.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
Figure 7: Circuit design of Composite part 2 with GSH gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>. Our construct | Figure 7: Circuit design of Composite part 2 with GSH gene. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>. Our construct | ||
includes a strong promoter, RBS, GSH and double terminator. | includes a strong promoter, RBS, GSH and double terminator. | ||
Line 198: | Line 197: | ||
<p> | <p> | ||
In order to make our gene compatible with RFC 10, 25 and 1000, we reconstructed the nucleotides to get rid of the restriction sites while protecting the amino acid | In order to make our gene compatible with RFC 10, 25 and 1000, we reconstructed the nucleotides to get rid of the restriction sites while protecting the amino acid | ||
− | sequence. We looked through the codon bias property of E.coli and made the nucleotide changes accordingly. | + | sequence. We looked through the codon bias property of <i>E. coli</i> and made the nucleotide changes accordingly. |
</p> | </p> | ||
<img src="https://static.igem.org/mediawiki/2018/8/87/T--METU_HS_Ankara--cparts012566.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/8/87/T--METU_HS_Ankara--cparts012566.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
Figure 8: Because Glutathione prevents ROS from harming the bacteria, increase in cell mas was observed in high concentrations of Glutathione. In brief, when | Figure 8: Because Glutathione prevents ROS from harming the bacteria, increase in cell mas was observed in high concentrations of Glutathione. In brief, when | ||
− | + | Glutathione concentration increases, the specific cell growth rate also increases and we observe an increase in the number of bacteria compared to the bacteria without | |
the GSH gene (Kim & Hahn , 2013). | the GSH gene (Kim & Hahn , 2013). | ||
</i> | </i> | ||
Line 212: | Line 211: | ||
<img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
Figure 9: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a> check with GSH specific primers. Expected band length: 225 bp. | Figure 9: <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a> check with GSH specific primers. Expected band length: 225 bp. | ||
Last six wells show positive results. | Last six wells show positive results. | ||
Line 222: | Line 221: | ||
We’ve inserted the GSH composite part to pSB1C3 backbone. Then, we’ve transformed the construct for submission, | We’ve inserted the GSH composite part to pSB1C3 backbone. Then, we’ve transformed the construct for submission, | ||
<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>, (in pSB1C3) | <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571005">BBa_K2571005</a>, (in pSB1C3) | ||
− | to Dh4 alpha and conducted colony PCR. We’ve prepared the PCR with GSH specific primers and expected to see a result of | + | to Dh4 alpha and conducted colony PCR. We’ve prepared the PCR with GSH specific primers and expected to see a result of 225 bp. By showing the |
− | band we expected, | + | band we expected, 225 bp, PCR confirmation for our insertion proved right. |
</p> | </p> | ||
</div> | </div> | ||
Line 243: | Line 242: | ||
in order to act upon furfural presence in the field (Zheng, 2013). The metabolism of furfural by NAD(P)H-dependent oxidoreductases will | in order to act upon furfural presence in the field (Zheng, 2013). The metabolism of furfural by NAD(P)H-dependent oxidoreductases will | ||
reduce the toxicity of the chemical by turning it into a derivative, furfuryl alcohol, and increase the furfural tolerance (Zheng, 2013; | reduce the toxicity of the chemical by turning it into a derivative, furfuryl alcohol, and increase the furfural tolerance (Zheng, 2013; | ||
− | Wang <i>et al.</i>, 2013; Allen <i>et al.</i>, 2010). Our second protein coding region, bifunctional gamma-glutamate-cysteine ligase/ | + | Wang <i>et al.</i>, 2013; Allen <i>et al.</i>, 2010). Our second protein coding region, bifunctional gamma-glutamate-cysteine ligase/Glutathione |
synthetase (GSH), is a non-protein thiol group and a tripeptide composed of cysteine, glycine and glutamic acid (Lu, 2013). It is crucial | synthetase (GSH), is a non-protein thiol group and a tripeptide composed of cysteine, glycine and glutamic acid (Lu, 2013). It is crucial | ||
for the detoxification of reactive oxygen species and free radicals (Ask <i>et al.</i> 2013). Reactive oxygen species (ROS) are harmful substances | for the detoxification of reactive oxygen species and free radicals (Ask <i>et al.</i> 2013). Reactive oxygen species (ROS) are harmful substances | ||
Line 263: | Line 262: | ||
<img src="https://static.igem.org/mediawiki/2018/d/dc/T--METU_HS_Ankara--cparts01256eie6.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/d/dc/T--METU_HS_Ankara--cparts01256eie6.jpg" /> | ||
<br> | <br> | ||
− | <i | + | <i class="parts-info"> |
Figure 10: Circuit design of Composite part 3 with FucO and GSH genes. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">BBa_K2571006</a>. | Figure 10: Circuit design of Composite part 3 with FucO and GSH genes. <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2571006">BBa_K2571006</a>. | ||
Our construct includes a strong promoter, RBS, FucO, RBS, GSH and double terminator. | Our construct includes a strong promoter, RBS, FucO, RBS, GSH and double terminator. | ||
Line 288: | Line 287: | ||
<img src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | ||
− | <i | + | <i class="parts-info"> |
− | Figure 11: BBa_K2571006 check with GSH and FucO specific primers. Expected band length:194 bp. | + | Figure 11: BBa_K2571006 check with GSH and FucO specific primers. Expected band length: 194 bp. Green boxes show positive results. |
</i> | </i> | ||
Latest revision as of 15:13, 17 October 2018